| Product NDC: | 61727-341 |
| Proprietary Name: | Influenzinum |
| Non Proprietary Name: | Influenzinum 9C |
| Active Ingredient(s): | 9; 9 [hp_C]/4g; [hp_C]/4g & nbsp; Influenzinum 9C |
| Administration Route(s): | SUBLINGUAL |
| Dosage Form(s): | PELLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 61727-341 |
| Labeler Name: | Homeocare Laboratories |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Start Marketing Date: | 20121031 |
| Package NDC: | 61727-341-21 |
| Package Description: | 4 g in 1 TUBE (61727-341-21) |
| NDC Code | 61727-341-21 |
| Proprietary Name | Influenzinum |
| Package Description | 4 g in 1 TUBE (61727-341-21) |
| Product NDC | 61727-341 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Influenzinum 9C |
| Dosage Form Name | PELLET |
| Route Name | SUBLINGUAL |
| Start Marketing Date | 20121031 |
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
| Labeler Name | Homeocare Laboratories |
| Substance Name | INFLUENZA A VIRUS; INFLUENZA B VIRUS |
| Strength Number | 9; 9 |
| Strength Unit | [hp_C]/4g; [hp_C]/4g |
| Pharmaceutical Classes |